Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Atypical haemolytic uraemic syndrome in the eculizumab era: presentation, response to treatment and evaluation of an eculizumab withdrawal strategy

Published:2019-03-27 Issue:1 Volume:186 Page:113-124
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Neave Lucy¹^ORCID,Gale Daniel P.²,Cheesman Simon³,Shah Raakhee³,Scully Marie⁴^ORCID

Affiliation:

1. Department of Haematology University College London Hospitals NHS Foundation Trust LondonUK

2. UCL Centre for Nephrology University College London LondonUK

3. Department of Pharmacy University College London Hospitals NHS Foundation Trust LondonUK

4. Department of Haematology UCLH Cardiometabolic programme‐ NIHR UCLH/UCL BRC London UK

Funder

St Peter's Trust

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.15899

Reference37 articles.

1. Discontinuation of Eculizumab Maintenance Treatment for Atypical Hemolytic Uremic Syndrome: A Report of 10 Cases

2. Discontinuation of Eculizumab Treatment in Atypical Hemolytic Uremic Syndrome: An Update

3. How I treat: the clinical differentiation and initial treatment of adult patients with atypical hemolytic uremic syndrome

4. The use of ADAMTS13 activity, platelet count, and serum creatinine to differentiate acquired thrombotic thrombocytopenic purpura from other thrombotic microangiopathies

5. Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation;Blood Advances;2023-01-26

2. Plasma Exchange Therapy Using Solvent Detergent-Treated Plasma: An Observational Pilot Study on Complement, Neutrophil and Endothelial Cell Activation in a Case Series of Patients Suffering from Atypical Hemolytic Uremic Syndrome;Transfusion Medicine and Hemotherapy;2022

3. Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes;Clinical Kidney Journal;2021-01-24

4. A review of thrombotic microangiopathies in multiple myeloma;Leukemia Research;2019-10

5. Diagnostic testing for differential diagnosis in Thrombotic Microangiopathies;Turkish Journal of Hematology;2019-07-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3